about
Aminoglycoside modifying enzymes.Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.Pharmacology of cinoxacin in humans.Cinoxacin: mechanism of action, spectrum of activity, pharmacokinetics, adverse reactions, and therapeutic indications.Effects of divalent cations on binding of aminoglycoside antibiotics to human serum proteins and to bacteria.[Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin.]Renal extraction of gentamicin in anesthetized dogs.Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosaPharmacokinetics of gentamicin and kanamycin during hemodialysis.Renal pharmacology of netilmicin.Comparative distribution of gentamicin, tobramycin, sisomicin, netilmicin, and amikacin in interstitial fluid in rabbits.Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis.Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature.Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs.Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake.Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services.Gentamicin pharmacokinetic changes in induced acute canine nephrotoxic glomerulonephritisAntibiotic sensitivities in vitro of diverse spiroplasma strains associated with plants and insects.Antibiotic levels in pericardial fluid.Levels of carbenicillin, ticarcillin, cephalothin, cefazolin, cefamandole, gentamicin, tobramycin, and amikacin in human serum and interstitial fluidEffects of hydration on gentamicin excretion and renal accumulation in furosemide-treated rats.Plasma and tissue protein binding of drugs in pharmacokinetics.Gentamicin dosing strategy in patients with end-stage renal disease receiving haemodialysis: evaluation using a semi-mechanistic pharmacokinetic/pharmacodynamic model.Comparison of the distribution of tobramycin and gentamicin in body fluids of dogs.Effect of protein concentration and binding on antibiotic assays.Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin.Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.Cephalosporin and aminoglycoside concentrations in peritoneal capsular fluid in rabbits.Gentamicin intravenous infusion rate: effect on interstitial fluid concentration.Clinical pharmacology of tobramycin in infants.Gentamicin disposition kinetics in humans with spinal cord injury.The penetration of antibiotics into peritoneal fluid.Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.Chemoprophylactic and bactericidal efficacy of 80 mg gentamicin in a single and once-daily dosing.The prophylactic use of antibiotics in cell culture.Prediction of netilmicin disposition in neonates.Influence of binding on the toxicity of bilirubin.
P2860
Q34354185-BA32427F-A143-4DD1-ADDC-B4C24304F92EQ34437719-3FEF5F85-CB42-4493-BAD2-A7EF187E648CQ34570930-65A0955E-BBB9-4E0E-B500-DDE9E78D2173Q34697653-CAE24CC7-11CF-4A28-A1AE-CCF2BF32F5FAQ34712753-94B8CA60-31BA-4C1E-8DE6-DA80154E7C71Q34919769-C243C6F1-6326-4F1B-925C-53D73BE427A0Q34947862-2B75F08F-8E90-49A1-B4E2-3A9DD9B0F958Q34978823-4E81AE33-638B-429E-B3D2-DA568249406CQ35657703-192AD532-F3BF-4D3B-9A21-A32CB27E6DCFQ35660758-4DCD5258-2E5D-403F-81BE-61BFBE241D73Q36462864-53E60FE0-F77C-4B5D-AA43-0D43B862180AQ36467335-70D98E23-52B7-4E28-89C8-F4CCD72207C7Q36473857-EDC1E0DC-613A-48A5-9D4A-A08881EBD2F5Q36863646-98914483-F486-4C15-B94A-2D1E4B315181Q38244221-62B31008-BB36-4DF3-8363-D0BB8887E0B2Q38653256-F7215324-5536-4073-BF5F-7A21536CD456Q38895149-E994DF3D-1CD2-4551-8754-4188804FA4C4Q39598341-FC07CFE6-3421-46E6-9611-2CA91DB0139BQ39855769-EDF774EB-F4A7-412C-B0E5-A448A0E94B91Q40079337-265A3EFC-747B-4DD1-B55D-E268A7E7CF02Q40367728-2030759E-A0B8-40EC-AF97-BB57C13EC992Q40617194-F05750FA-A0AE-48F2-A921-7A9FF3026BA0Q40618962-4CA97E39-1466-45EA-A0FD-9B8EE8681D2FQ40809296-B9117D8F-62A3-40DB-AD81-11CBDEC8204FQ40857961-99597ED6-69F3-42F5-8ED7-E10090A231F3Q40943216-B347A288-9C1C-415F-A992-F6309A5E30DAQ40944241-9A933955-A057-42BC-9103-8C29AFB09419Q40945406-8565D55D-55DA-4DE7-BFB4-9F2791675702Q40947687-91257DAC-4633-4CBA-8AC9-F3BD38C65AD2Q40947803-012AAB78-A610-4CD9-9005-2AFC87AE82ABQ40948418-30C72C34-CED3-4B48-975F-E4DA4ED7BEDFQ41429787-3444DB9E-E86A-4D83-9439-9E5064A35EC8Q41496535-89A09ADD-6F10-4E0D-AAD3-BED99259A5A3Q43056362-4245F45B-B211-41C2-B547-EAD1781A2CB0Q44275415-8E444201-6349-46F5-8C90-A255F270A00CQ45191205-986E3E3C-1736-4E17-BA3F-CC78A26F8BD4Q47744147-0A7E4C48-4318-4F82-8D19-0E198DF5A098Q52861420-E13A5CBD-34E8-4BA5-8653-31B843685F72Q54300888-D4166738-9AC0-4649-A157-6902FA62E8BC
P2860
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
1972年论文
@zh
1972年论文
@zh-cn
name
Serum protein binding of the aminoglycoside antibiotics
@ast
Serum protein binding of the aminoglycoside antibiotics
@en
type
label
Serum protein binding of the aminoglycoside antibiotics
@ast
Serum protein binding of the aminoglycoside antibiotics
@en
prefLabel
Serum protein binding of the aminoglycoside antibiotics
@ast
Serum protein binding of the aminoglycoside antibiotics
@en
P2093
P2860
P356
P1476
Serum protein binding of the aminoglycoside antibiotics
@en
P2093
P2860
P304
P356
10.1128/AAC.2.3.214
P407
P577
1972-09-01T00:00:00Z